Earnings History Data for MDxHealth SA (MDXH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

MDxHealth SA

MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. MDxHealth SA is based in Belgium.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-11-2024	PM	MDXH	MDxHealth SA	55.67	-0.40	-0.27	0.00	MDxHealth SA Non-GAAP EPS of -$0.40, revenue of $23.3M [11/7/2024 6:30 AM]	2.08	0.0 (0.00%)	2.01	-0.07 (-3.37%)	1.95 - 4.64	318,758	60,000	2,494
MDxHealth SA Non-GAAP EPS of -$0.40, revenue of $23.3M [11/7/2024 6:30 AM] What To Expect From MDxHealth SA (MDXH) Q3 2024 Earnings [Nov-05-24 08:08AM]
21-08-2024	AH	MDXH	MDxHealth SA	86.23	-0.31	-0.26	0.00	MDxHealth SA GAAP EPS of -$0.42, revenue of $22.16M beats by $1.07M [8/21/2024 4:02 PM]	2.88	-0.39 (-12.03%)	3.40	0.13 (3.94%)	2.15 - 4.64	191,471	40,000	2,265
MDxHealth SA GAAP EPS of -$0.42, revenue of $22.16M beats by $1.07M [8/21/2024 4:02 PM]
01-05-2024	PM	MDXH	MDxHealth SA	0.00	-0.31	-0.30	0.00	MDxHealth SA GAAP EPS of -$0.31, revenue of $19.8M [5/1/2024 1:32 PM]	2.65	0.15 (6.00%)	0.0	0.0 (0.00%)	2.15 - 4.64	44,814	30,000	0
MDxHealth SA GAAP EPS of -$0.31, revenue of $19.8M [5/1/2024 1:32 PM]
06-03-2024	AH	MDXH	MDxHealth SA Sponsored ADR	0.00	-0.39	-0.28	0.00	MDxHealth SA GAAP EPS of -$0.39 misses by $0.08, revenue of $19.39M beats by $0.46M [3/6/2024 4:43 PM]	3.11	-0.62 (-16.62%)	3.70	-0.03 (-0.80%)	2.15 - 4.64	369,187	40,000	822
MDxHealth SA GAAP EPS of -$0.39 misses by $0.08, revenue of $19.39M beats by $0.46M [3/6/2024 4:43 PM]
08-11-2023	AH	MDXH	MDxHealth SA	49.19	-0.40	-0.31	-0.05		2.71	-0.39 (-12.58%)	3.12	0.08 (2.63%)	2.15 - 8.51	117,874	40,000	816

23-08-2023	AH	MDXH	MDxHealth SA Sponsored ADR	95.00	-0.30	-0.32	0.00		3.46	-0.22 (-5.98%)	3.60	-0.08 (-2.17%)	2.47 - 8.80	182,577	130,000	17,035

15-05-2023	AH	MDXH	MDxHealth SA Sponsored ADR	63.00	-0.05	-0.40	0.00		4.15	0.47 (12.77%)	3.92	0.24 (6.48%)	2.47 - 10.95	1,369,934	170,000	33,547

27-10-2022	AH	MDXH	MDxHealth SA Sponsored ADR	98.00	-0.05	-0.55	0.00		7.01	0.61 (9.53%)	0.0	0.0 (0.00%)	6.00 - 13.17	2,397	0	0

02-08-2022	AH	MDXH	MDxHealth SA	107.93	N/A	-0.55	0.00	MDxHealth SA reports Q2 results [8/2/2022 5:15 PM]	7.61	0.87 (12.90%)	7.82	1.08 (16.02%)	6.20 - 13.17	11,484	0	401
MDxHealth acquires Oncotype DX prostate test from Exact Sciences [8/2/2022 6:54 PM] MDxHealth SA reports Q2 results [8/2/2022 5:15 PM] Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results [Aug-02-22 04:00PM]
27-04-2022	AH	MDXH	MDxHealth SA Sponsored ADR	93.00	-0.05	-0.55	0.00	MDxHealth SA GAAP EPS of -$0.05 beats by $0.47, revenue of $6.11M beats by $0.1M [4/27/2022 5:41 PM]	8.49	0.61 (7.74%)	0.0	0.0 (0.00%)	7.01 - 13.17	1,504	0	0
MDxHealth SA GAAP EPS of -$0.05 beats by $0.47, revenue of $6.11M beats by $0.1M [4/27/2022 5:41 PM] MDxHealth Reports Q1-2022 Results [Apr-27-22 04:00PM]